Jynarque Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Jynarque
V
- valoctocogene roxaparvovec
- valsartan
- Valturna (aliskiren / valsartan)
- Vanatol LQ (acetaminophen / butalbital / caffeine)
- Vanatol S (acetaminophen / butalbital / caffeine)
- Vaprisol (conivaptan)
- Varubi (rolapitant)
- Varubi IV (rolapitant)
- Vascor (bepridil)
- Vaseretic (enalapril / hydrochlorothiazide)
- Vasotec (enalapril)
- Veklury (remdesivir)
- Velban (vinblastine)
- Vemlidy (tenofovir alafenamide)
- vemurafenib
- Venclexta (venetoclax)
- venetoclax
- VePesid (etoposide)
- verapamil
- Verelan (verapamil)
- Verelan PM (verapamil)
- Vestura (drospirenone / ethinyl estradiol)
- Vfend (voriconazole)
- Victrelis (boceprevir)
- Vida Mia Pain Relief (aspirin/citric acid/sodium bicarbonate)
- Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Vijoice (alpelisib)
- viloxazine
- vinblastine
- Vincasar PFS (vincristine)
- vincristine
- vincristine liposome
- vinorelbine
- Viracept (nelfinavir)
- Viramune (nevirapine)
- Viramune XR (nevirapine)
- Viread (tenofovir disoproxil)
- Virt-Phos 250 Neutral (potassium phosphate / sodium phosphate)
- Virtrate-3 (citric acid/potassium citrate/sodium citrate)
- Vis-Phos N (potassium phosphate / sodium phosphate)
- vismodegib
- Vitetal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Vitrakvi (larotrectinib)
- Vivitrol (naltrexone)
- voclosporin
- Vonjo (pacritinib)
- Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan)
- voriconazole
- Votrient (pazopanib)
- voxelotor
- Voydeya (danicopan)
- Vtol LQ (acetaminophen / butalbital / caffeine)
- Vyduo (nebivolol / valsartan)
- Vyxeos (cytarabine liposomal / daunorubicin liposomal)
More about Jynarque (tolvaptan)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.